Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds JP Morgan Downgrades Bioventus to Underweight

JP Morgan Downgrades Bioventus to Underweight

JP Morgan analyst Robbie Marcus downgrades Bioventus (NASDAQ:BVS) from Overweight to Underweight.

byBenzinga Newsdesk

November 9, 2022

1 minute read

JP Morgan analyst Robbie Marcus downgrades Bioventus (NASDAQ:BVS) from Overweight to Underweight.

News

‘Resideo Announces Subscription Partnership With FilterEasy’

By Benzinga Newsdesk

December 18, 9:18 AM

https://www.resideo.com/us/en/corporate/newsroom/all-articles/Resideo-announces-subscription-partnership-with-FilterEasy/Company launches first direct-to-consumer subscription service Resideo Technologies, Inc., a

REZI

Analyst Ratings

Analyst Expectations for Southern’s Future

By Benzinga Insights

August 23, 9:00 AM

Southern (NYSE:SO) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

Qiagen Has Steady Income And Defensive Growth Potential, Goldman Sachs Upgrades Stock

By Vandana Singh

December 7, 2:39 PM

Qiagen NV (NYSE: QGEN) has a steady income from selling tools for preparing samples and diagnostics.

QGEN

Boeing Reports Increased Orders, Deliveries In September

By Vandana Singh

October 11, 2:53 PM

Boeing Co’s (NYSE:BA) deliveries rose in September to 51 airplanes, while orders rose by 90. Last month, Boeing had 51 new…

AAL

JP Morgan Downgrades Bioventus to Underweight

Related Posts

‘Resideo Announces Subscription Partnership With FilterEasy’

Analyst Expectations for Southern’s Future

Qiagen Has Steady Income And Defensive Growth Potential, Goldman Sachs Upgrades Stock

Boeing Reports Increased Orders, Deliveries In September